Pluripotency is accompanied by the erasure of parental epigenetic memory with naïve pluripotent cells exhibiting global DNA hypomethylation both in vitro and in vivo. Exit from pluripotency and priming for differentiation into somatic lineages is associated with genome-wide de novo DNA methylation. We show that during this phase, coexpression of enzymes required for DNA methylation turnover, DNMT3s and TETs, promotes cell-to-cell variability in this epigenetic mark. Using a combination of single-cell sequencing and quantitative biophysical modelling, we show that this variability is associated with coherent, genome-scale, oscillations in DNA methylation with an amplitude dependent on CpG density. Analysis of parallel single-cell transcriptional and epigenetic profiling provides evidence for oscillatory dynamics both in vitro and in vivo. These observations provide fresh insights into the emergence of epigenetic heterogeneity during early embryo development, indicating that dynamic changes in DNA methylation might influence early cell fate decisions.
Introduction
In mammalian embryonic development, the segregation of lineages giving rise to different somatic tissues is associated with large-scale changes in DNA methylation (5-methylcytosine). Following fertilisation, global loss of DNA methylation 3 from both the maternal and paternal genomes is tightly linked with the acquisition of naïve pluripotency in the inner cell mass of the blastocyst . During the transition towards the primed pluripotent state of the epiblast, de novo methylation results in a global gain of this epigenetic mark (Auclair et al., 2014; Seisenberger et al., 2012; Smith et al., 2012; Wang et al., 2014) . A similar event occurs in vitro during the transition from naïve to serum primed embryonic stem cells (ESCs) and then exit from pluripotency (Ficz et al., 2013; Habibi et al., 2013; Leitch et al., 2013; Takashima et al., 2014; von Meyenn et al., 2016) . However, during priming in ESCs not only are the de novo methyltransferases DNMT3A and B dramatically upregulated but paradoxically the hydroxylases TET1 and 2 remain highly expressed too. This observation has given rise to the hypothesis that the system may be dynamic with turnover of DNA methylation to hydroxymethylation (5hmC), formylcytosine (5fC), carboxycytosine (5caC) through base excision repair or DNA replication back to unmethylated cytosine . This could potentially lead to heterogeneous epigenetic states between cells in a population, with functional consequences for gene expression and cell phenotype. DNA methylation and chromatin dynamics have been quantitatively modelled in various genomic contexts in bulk datasets and in exquisite detail at single loci of biological significance (Atlasi and Stunnenberg, 2017; Berry et al., 2017; Bintu et al., 2016; Haerter et al., 2014; Kyriakopoulos et al., 2017) . However the availability recently of methylome information in single cells from single-cell whole genome bisulfite sequencing (scBS-seq, Farlik et al., 2015; Smallwood et al., 2014) provides an unprecedented opportunity for studying and modelling DNA methylation dynamics genome-wide in a population of cells undergoing a biological transition. Indeed scBS-seq has revealed profound methylation heterogeneity in ESCs particularly in enhancers (Farlik et al., 2015; Smallwood et al., 2014) . Here we combine single-cell sequencing with biophysical modelling to study how DNA methylation heterogeneity and dynamics arise during the transition from naïve to primed pluripotency, and the exit from pluripotency in vivo. We find evidence for genome-scale oscillatory dynamics in these cells with a link to primary transcripts, suggesting that heterogeneity can be created by molecular processes on different scales.
Results

Heterogeneous methylation distributions in primed ESCs
To study DNA methylation heterogeneity during the phase of lineage priming we began by considering ESCs, which serve as a powerful in vitro model for cells transiting from naïve through primed pluripotency and into early cell fate decision-making (Kalkan et al., 2017) . scBS-seq measurements have shown that methylation heterogeneity in ESCs is greatest at enhancer elements (e.g. H3K4me1 sites and low methylated regions (LMRs) (Stadler et al., 2011) ) (Smallwood et al., 2014) . By analysing scBS-seq data separately for naïve and serum conditions, we found that increased variance at H3K4me1 sites was specific to primed ESCs ( Figures 1A and S1A) , with cell averages varying between 17% and 86% (Figures 1B and 1C) . (Note that, to avoid potential systematic variations in DNA methylation during the cell cycle, ESCs were isolated based on their DNA content and were predominantly positioned in the G0/G1 phase.) By contrast, naïve ESCs showed minimal cell-to-cell variability at H3K4me1 sites ( Figures 1B, 1C and S1A).
Although other genomic elements showed proportionately less variability, levels of DNA methylation at these sites were found to be tightly correlated with those at enhancer regions and highly coherent for CpG poor elements (Figures 1D and S1B). DNA methylation heterogeneity in enhancer regions therefore is a reflection of synchronized (coherent) changes that affect the DNA on a genome scale.
Methylation of cytosine residues is catalysed by the de novo DNA methyltransferase (DNMT3A/B) enzymes, while ten-eleven translocase (TET1/2/3) enzymes act in a multi-step process that can remove DNA methylation (Wu and Zhang, 2014) . Importantly, primed ESCs express both Dnmt3a/b and Tet1/2, while naïve ESCs express Dnmt3a/b at much reduced levels ( Figure S2A ), raising the possibility that DNA methylation heterogeneity is dependent on this paradoxical co-expression . Consistently, we observed a loss of DNA methylation heterogeneity during differentiation to embryoid bodies, where Tet and Dnmt3 are downregulated ( Figures S2A and S2B ). Analysis of parallel single-cell DNA methylome and transcriptome sequencing (scM&T-seq) data (Angermueller et al., 2016) showed that DNA methylation heterogeneity at H3K4me1 marks is largely confined to the most pluripotent sub-population, which express the highest levels of Dnmt3a/b and Tet1/2 ( Figure S2C ). Furthermore, deletion of Dnmt3a/b resulted in homogeneously low DNA methylation levels, while loss of Tet1-3 led to uniformly high DNA methylation ( Figure 1E and S2D).
How does this strongly correlated DNA methylation heterogeneity arise during the transition from naïve to primed pluripotency? One possibility is that methylation differences between primed ESCs reflect slow dynamic 5 changes in the expression of DNMT3A/B and TET1/2 arising, for example, through transcriptional state switching (Singer et al., 2014) . However, although DNA methylation heterogeneity is dependent on the coexpression of genes that drive methylation and demethylation, analysis of scM&T-seq data (Angermueller et al., 2016) shows that global methylation levels (i.e. the genome-wide mean methylation rates) are largely independent of their ( Figure 1F , R 2 =0.06). Moreover, DNA methylation is dynamic in primed conditions (Singer et al., 2014) and, as a system in steadystate, it follows that such dynamics must be recurrent. Such recurrent dynamics could be achieved by DNA methylation switching stochastically and reversibly between discrete levels or, alternatively, by continuously oscillating. Crucially, since we observe strong genome-wide coherence in DNA methylation levels ( Fig. 1D ), such recurrent changes in DNA methylation must be synchronized (i.e. coherent) across the genome.
Modelling dynamics of DNA methylation
To assess whether DNA methylation turnover could give rise to oscillatory dynamics, we turned to a modelling approach. Importantly, our approach was constrained by the observed genome-wide coherence of DNA methylation levels, placing emphasis on finding a description based on collective degrees of freedom. We therefore set out to ask whether and how collective dynamics in DNA methylation can emerge despite the plethora of complex heterogeneities that can influence DNA methylation locally.
We began by considering the dynamics of a single CpG site, which can assume several different states including an unmodified cytosine (C), a methylated cytosine (5mC), a hydroxymethylated cytosine (5hmC), and other states.
Notably, the biochemistry of DNA methylation turnover involves a cyclical process: The binding and action of DNMT3A/B drives conversion of C to 5mC (Baubec et al., 2015; Jia et al., 2007) , while demethylation occurs through a long sequence of intermediary steps, each requiring the binding and release of enzymes, and ultimately the excision of intermediates and DNA repair or DNA replication ( Figure 2A ). Importantly, DNMT3A/B has been shown to bind cooperatively to the DNA (Emperle et al., 2014) , implying that de novo methylation is autocatalytic. Meanwhile, the removal of DNA methylation effectively leads to a time delay, , between the removal of the 5mC mark and the reestablishment of the unmodified cytosine. Given the known coupling between histone modifications, chromatin remodelling and DNA methylation (Du et al., 2015; Iurlaro et al., 2017) , it is likely that these different levels of 6 regulation contribute to the nonlinear feedback of DNA methylation on itself. Mathematically, we reasoned that the time evolution of C and 5mC concentrations, ( ) and ( ), averaged across the genome, can therefore be captured by the minimal coupled set of rate equations (Supplementary Theory),
with and defining effective chemical conversion rates from C and 5mC, respectively. If the time delay is sufficiently long, de novo methylation of initially hypomethylated genomic regions will result in rapid depletion of the pool of unmodified cytosines, which is then filled again due to the delayed conversion of 5mC to C. This can then lead to sustained oscillations in the levels of C and 5mC through a mechanism termed a Hopf bifurcation ( Figure 2B and 2C). Importantly, although we do not know the effective conversion rates and in living cells, the fact that the model predicts coherent oscillations for low values of the dimensionless parameter suggests that coherent oscillations can occur under biologically relevant conditions. Indeed, distributions of methylation rates obtained from stochastic simulation of the dynamics resemble closely the experimental distributions obtained by scBS-seq ( Figure 2D ,
Supplementary Movie 1 and Supplementary Note).
Although this simple model captures the essence of how global oscillations may emerge from the biochemistry of DNA methylation turnover, its validity relies implicitly on some mechanism by which information on methylation levels is transported throughout the genome. How can such collective behaviour, as indicated by the experimental data, arise given the known heterogeneity of local factors influencing DNA methylation? To answer this question, we turned to a more ab initio modelling approach, considering the stochastic dynamics of individual CpG sites which, according to the biochemistry of DNA methylation turnover, cycle through multiple chemical states stochastically with a locus-specific rate. We hypothesised that coherent collective dynamics can emerge as a result of the autocatalytic binding of DNMT3A/B enzymes. These enzymes can methylate multiple neighbouring CpGs at the same time, leading to their effective short-range coupling (Haerter et al., 2014) . At the same time, DNMT3A/B enzymes preferentially bind to 5mC, which represses active degradation of these enzymes and thereby leads to global positive feedback on DNA methylation ( Figure 2E ). We took both local and global feedback to be locally heterogeneous mirroring local variations in enzyme binding affinity (conferred e.g. by different chromatin contexts).
(1)
To investigate whether locally heterogeneous interactions can give rise to global oscillations of DNA methylation, we successively coarse grained the stochastic dynamics starting from CpG dense regions and progressing to CpG poor regions (using an approach known as strong coupling renormalisation). For further details of the method and its current application, see Supplementary Theory. During this process, neighbouring blocks of CpGs become increasingly uncoupled, such that the coarse grained local phase dynamics is effectively described by a heterogeneous Kuramoto model,
with continuous phases, / , and effective intrinsic frequencies 1 / and couplings /. The dynamics is therefore described effectively by a set of globally coupled driven oscillators. Just as our phenomenological model, the heterogeneous Kuramoto model exhibits collective oscillations through a Hopf bifurcation if the average coupling through DNMT3A/B binding is sufficiently strong,
where ( 1 D ) of the probability of the most abundant oscillator frequency.
This result suggests that, first, coherent oscillations can occur due to local and global feedback by DNMT3A/B enzymes, and that this effect is enhanced by heterogeneity in DNMT3A/B binding affinities. Second, if DNMT3A/B mediate global DNA methylation oscillations we expect the oscillation amplitude in a given genomic region to be proportional to the rate of DNMT3A/B binding in this region. Third, due to the cyclic nature of DNA methylation turnover, the local frequency should, at least transiently, be inversely proportional to the rate of DNMT3A/B binding.
Importantly, it is these predictions that we use to challenge the basis of the model below using the experimental findings.
Evidence for rapid DNA methylation oscillations upon serum priming
To obtain more direct evidence for genome-scale DNA methylation oscillations, and to test these model predictions, we next considered an in vitro "2i release" model in which cells were transferred from naïve "2i" to primed "serum" 8 culture conditions and bulk cell samples were collected for BS-seq over a subsequent time-course ( Figure 3A ). As naïve ESCs show homogeneously low DNA methylation levels ( Figure 1C ), we reasoned that transfer from naïve to primed conditions might synchronise their entry into an oscillatory phase, allowing direct evidence for oscillations to be acquired from population-based measurements. Strikingly, we detected evidence for rapid oscillations in the mean methylation rate over H3K4me1 as well as exons (p=2e-4), introns (p=8e-7), promoters (p=0.01) and genome-wide (p=1e-51) ( Figures 3E and S3C ). In agreement with the model, from the spectral analysis, we found that the period of oscillations during the release from 2i differed between genomic elements ( Figure 3E and S3C), being longer at specific enhancer regions known to repress DNMT3 binding than elsewhere. Indeed, this initial variability in periodicity indicates that oscillations in DNA methylation are not driven extrinsically by a global (genetic) oscillator, such as Hes1 (Kobayashi and Kageyama, 2011) , which would lead to the same single harmonic at all regions of the genome.
The amplitude of genome-wide oscillations was seemingly modest; however, global averages in bulk measurements represent only the residual signal after averaging over many noisy elements, and may be confounded by cell-to-cell variability in the timing of DNMT3A/B up-regulation upon priming such that these measurements can only provide a lower bound for the amplitude. Indeed, oscillations with substantially greater amplitude were found upon inspection of specific H3K4me1 sites ( Figures 3E and S3D ). Oscillations were more subtle in a repeat experiment and could not be rigorously resolved with the coverage depth available in whole-genome bisulfite sequencing.
However, using amplicon bisulfite sequencing (AmpBS-seq) to target 14 loci (Table S2 ) at H3K4me1 sites that showed evidence of oscillatory dynamics in the initial 2i release experiment, we confirmed oscillations at 4 of these 14 loci upon 2i release using spectral analysis ( Figure 3D and S3D), while no oscillations were observed in cells that remained in 2i media. Furthermore, when considering a larger set of 35 loci by AmpBS-seq, spectral analysis revealed significantly enriched oscillations compared to the control experiment (p=0.05, Fisher's test).
To explore the potential functional impact of DNA methylation oscillations on transcription, we performed an RNA sequencing time course of the same samples after release from 2i conditions. While results for exonic reads were ambiguous, we found significant correlations in enhancer and intronic reads with global DNA methylation levels ( Figure   9 3F). This difference in the strength of correlation in exonic and non-exonic reads could be a reflection of the shorter half-lives of these primary transcripts compared to mature mRNA.
Oscillations are CpG density-dependent
To further probe the mechanistic basis of DNA methylation oscillations and challenge the model predictions, we returned to the initial 2i release experiment to investigate whether oscillations were equally prevalent across the genome or preferentially enhanced in specific genomic elements. The locally averaged distance between neighbouring CpGs, or its inverse, the CpG density, defines a natural scale in the context of DNA methylation (Lövkvist et al., 2016) .
We therefore tiled the genome into windows of variable length, but constant local sequencing coverage (50 informative CpGs), to account for varying CpG coverage (see Figure 4A for details of the approach). For each window, we then determined the CpG density and the amplitude of oscillation upon 2i release. We found that the amplitude diverged at a characteristic value of the CpG density of around 2.5%, while oscillations were largely suppressed at CpGrich regions ( Figure 4B ).
Based on this observation, we returned to the scBS-seq data for primed ESCs in steady state and calculated how much cell-to-cell variability in DNA methylation exceeds that expected from technical noise. To estimate biological variability for a given locus, and to take into account confounding factors to methylation variance, we followed previous work and considered the ratio of methylation variance across cells and the technical variance expected for a given combination of mean methylation and coverage (see Methods). Notably, we found the same CpG densitydependent divergence as for the amplitude of oscillations after 2i release ( Figure 4C ), consistent with our hypothesis that methylation heterogeneity in primed ESCs derives from oscillatory dynamics. Moreover, the divergence in the strength of oscillations coincides with the measured CpG density-dependence of DNMT3A/B binding affinity ( Figure   4D ) suggesting that, in agreement with the model, coherence is mediated through DNMT3A/B binding.
Evidence for coherent oscillations of DNA methylation in vivo
Noting that the transcriptional and epigenetic changes that occur in ESCs following their transfer from 2i to serum conditions resemble those seen in vivo during the exit from pluripotency (Kalkan et al., 2017) , we then questioned whether oscillatory DNA methylation dynamics can be observed in the embryo. Indeed, during this transition (E4.5 to E5.5 epiblast), there is a substantial increase of Dnmt3a and b transcript levels while Tet1 remains highly expressed (Boroviak et al., 2015; Mohammed et al., 2017) , suggesting that co-expression of these enzymes could drive oscillations in vivo. We therefore analysed parallel scM&T sequencing of epiblast cells at E4.5, E5.5 and E6.5 (Argelaguet et al., unpublished) . Once again, we observed cell-to-cell variability in the levels of DNA methylation at primed ESC enhancer sites ( Figures 5A and S4A) . At E4.5 and E6.5, global DNA methylation correlates with transcriptional changes associated respectively with early and late lineage priming (Argelaguet et al., unpublished) .
However, at E5.5, as in primed ESCs, global methylation levels at enhancers were largely independent of Dnmt3 and
Tet expression levels in the same cell ( Figure 5B , ? = 0.12) and the transcriptome did not show any early signs of lineage priming (Mohammed et al., 2017; Peng et al., 2016) . Moreover, at this time point, DNA methylation heterogeneity was also independent of any genes that vary spatially across the embryo at E6.5 (Supplementary Theory) (Scialdone et al., 2016) .
Based on these observations, we hypothesised that the heterogeneity of DNA methylation at E5.5 is a consequence of de novo methylation or oscillatory turnover. But how can oscillatory dynamics be identified from a purely static measure, such as that provided by single-cell sequencing? To address this question, we first sought to identify statistical patterns in DNA methylation that are specific for oscillatory DNA methylation. We reasoned that static measurements of a population of cells exhibiting oscillations around the same centre point would, with higher probability, reflect cells at the extrema of the oscillation than at intermediary values. Therefore, if the progressive increase in de novo methylation is superimposed with oscillatory dynamics, the distribution of the average levels of DNA methylation would become bimodal both at the onset of this transition and when DNA methylation has reached saturation levels ( Figure 5C At E5.5, when global DNA methylation levels were near maximal level, we found that the distribution of methylation was indeed bimodal in enhancer regions (p<1e-16) and other genomic contexts ( Figures 5E,F and S4B) , consistent with oscillatory DNA methylation. To further challenge the association of bimodality with oscillatory dynamics, we tiled the genome into coverage-based windows and used a statistical (dip) test to assess whether DNA methylation in a given window is bimodally distributed between cells. In excellent agreement with the divergence of the oscillation amplitude after 2i release and in serum conditions, the bimodal signature was strongest for elements with approximately 2.5% CpG density ( Figures 5F,G and S4B) . Further, independent of CpG density, we compared genomic regions at different stages of the de novo methylation process. In agreement with oscillatory dynamics ( Figure   5D ), and independent of CpG density, bimodality was only pronounced at hypomethylated or hypermethylated regions, but not at regions with intermediary methylation level ( Figure 5H ). Notably, although our analysis does not rule out early lineage commitment through DNA methylation heterogeneity, such a scenario cannot explain the observed CpG density-dependence of bimodality or the depletion of the bimodal pattern at regions with intermediary DNA methylation levels.
Finally, to obtain more direct evidence for DNA methylation oscillations in vivo, we sought to resolve oscillations by ordering cells according to an estimate of their "developmental age", i.e. the time since the initial upregulation of the Dnmt3 genes. To this end, we noted that CpG-rich regions do not show pronounced oscillations in vitro, and DNA methylation levels in these regions rise monotonically between E4.5 and E6.5 ( Figure 6A ). We therefore used global methylation levels in regions with a CpG density of between 10% and 15% to define a methylation "pseudotime" for individual cells (Supplementary Theory). Then, charting the average DNA methylation levels of genomic elements with CpG densities for which oscillations are expected to be most pronounced (i.e. between 2 and 3%) against pseudo-time, we found evidence of coherent oscillatory patterns, which were then confirmed using spectral analysis (p=6e-4, Figures 6B and 6C ). In common with the findings of the 2i release experiment, this oscillatory pattern was strongest at approximately 2.5% CpG density ( Figure S4B ).
Discussion
Transcriptional and epigenetic heterogeneity between cells is thought to be important for cell fate decision making during development (Torres-Padilla and Chambers, 2014), but the underlying molecular mechanisms are largely unknown. Using single-cell sequencing technologies, we have systematically investigated the dynamics of DNA methylation heterogeneity during the exit from pluripotency and priming for differentiation. By combining biophysical modelling and single-cell sequencing, we have revealed evidence for genome-scale oscillations in DNA methylation during the exit from pluripotency ( Figure 6D ). Mechanistically these oscillations appear to be driven by cooperative binding properties of the DNMT3 enzymes, which makes low CpG density sequences, including enhancers, a particular target. Signatures of oscillations are also present in embryos exiting pluripotency in vivo suggesting the possibility that they may contribute to cell fate decisions in embryogenesis.
Based on the DNA modification cycle, mathematical modelling predicts the emergence of genome-scale oscillations in DNA methylation in cells where both DNMT3 and TET enzymes are expressed. These conditions arise naturally during priming of ESCs and in epiblast cells in vivo, when DNMT3A/B levels increase strongly in cells already expressing TET1/2, before overt differentiation leads to the down-regulation of both DNMT3 and TET enzymes. The oscillation state is hence an intermediate between the naïve hypomethylated state and the differentiated state in which the majority of the enhancer sites in the genome are methylated. By synchronising cells in the naïve state and then measuring DNA methylation genome-wide at closely spaced time points upon serum priming, we were able to record robust oscillations in DNA methylation, which occurred with a period of approximately 2-3 hours. Given the multi-step cycle of cytosine modification turnover, these oscillations are remarkably fast. However, yet more rapid oscillations in DNA methylation (with a period of approximately 1.7 hours) have been observed in breast cancer cells at the pS2 promoter upon transcriptional activation (Kangaspeska et al., 2008; Metivier et al., 2008) .
DNA methylation oscillations in primed ESCs are more rapid than, and therefore must be autonomous of, the cell cycle and the rate of switching between transcriptional states. Of course, longer period transcriptional switching of the Tet genes may influence the oscillation dynamics at the population level (see below). However, it is notable that our model can yield oscillations at constant levels of DNMT3a/b and TET1/2 if one considers nonlinearities, such as autocatalytic and processive de novo methylation, where established 5mC marks catalyse further de novo methylation (Baubec et al., 2015) . In accordance with the model, we found that oscillations stalled at a low point of DNA methylation upon removal of Dnmt3a/b and at a high point upon Tet1/2 depletion.
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Our initial focus was on enhancer methylation, the sites of greatest heterogeneity in primed ESCs. This is consistent with LMRs and H3K4me1 sites being targeted by hydroxymethylation in ESCs and being the most methylation-variable sequences between tissues upon differentiation in vivo (Booth et al., 2012; Feldmann et al., 2013; Hon et al., 2013; Hon et al., 2014; Huang et al., 2014; Lu et al., 2014; Stadler et al., 2011; Ziller et al., 2013) . At first sight, the amplitude and the genome-scale synchronisation of oscillations might seem inconsistent with limited accessibility of DNA in condensed chromatin. However, transcription factor binding to enhancers and promoters disrupts the local nucleosome structure rendering chromatin more accessible, as reflected in DNAseI hypersensitivity and ATAC-seq assays. We found that many regions of the genome participate in oscillatory methylation in a manner that is dependent on CpG density.
With a period of 2-3 hours, DNA methylation is surprisingly dynamic, changing at a rate much faster than cell (F) Scatter plot comparing H3K4me1 methylation and transcription of DNA methylation modification enzymes in scM&T-seq data from 'More Pluripotent' primed ESCs (see Figure S2C ). The size of dots is proportional to global methylation coverage. for different genomic features (see also Figure S3C ). Red dots denote significant enrichment of a given period (p<0.05).
Thin lines denote standard error. (F) Comparison between the DNA methylation time course in H3K4me1 regions (see also (Baubec et al., 2015) . We tiled the genome into 1kbp tiles with an overlap of 500bp and added 8 pseudo counts per element. 
